Publications in collaboration with researchers from Instituto de Investigación Sanitaria La Fe (2)

2025

  1. Phase 1 first-in-human dose-expansion study of the oral SF3B1 modulator H3B‑8800 in lower-risk myelodysplastic syndrome

    Leukemia Research, Vol. 156

  2. Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study

    Cancer, Vol. 131, Núm. 1